PARASITOLOGY RESEARCH, published by Springer, stands as a pivotal journal in the fields of parasitology, infectious diseases, and insect science, with a rich history dating back to 1987. Operating from Germany, this journal has garnered an impressive reputation, achieving a high ranking within various categories, including Q1 in Veterinary (miscellaneous) and Q2 across several relevant fields as of 2023. While it does not currently offer Open Access options, the journal remains a vital resource for researchers, professionals, and students seeking to contribute to and keep pace with advancements in parasitological studies. With a commitment to publishing high-quality research, PARASITOLOGY RESEARCH serves as an essential forum for disseminating findings that enhance our understanding of parasitic organisms and their impacts on health and the environment. Explore this journal to engage with cutting-edge investigations and reviews that drive innovation in parasitology and related disciplines.

CURRENT OPINION IN INFECTIOUS DISEASES, published by Lippincott Williams & Wilkins, is a premier journal that focuses on the latest developments and understanding in the field of infectious diseases. With its ISSN 0951-7375 and E-ISSN 1473-6527, this journal has gained recognition for its pivotal role in advancing knowledge from 1988 to its current publications in 2024. Boasting an impressive Q1 ranking in both Infectious Diseases and the Medical Microbiology category, it holds a reputable position among the top journals in the field. The journal serves as an essential resource for researchers, professionals, and students alike, providing them with timely reviews, analyses, and perspectives that shape contemporary practice and policy. While lacking open access options, it ensures a critical examination of emerging trends and unique insights that foster informed discussions. With its consistently high impact factor, CURRENT OPINION IN INFECTIOUS DISEASES remains a vital platform for thought leaders and innovators navigating the complexities of infectious disease research.

PARASITE IMMUNOLOGY, published by Wiley, is a leading journal in the field of immunology and parasitology, with an ISSN of 0141-9838 and E-ISSN of 1365-3024. Since its inception in 1979, it has played a pivotal role in advancing our understanding of host-parasite interactions, immunological responses to parasitic infections, and the mechanisms of immunological resistance. The journal is adeptly positioned within the academic community, currently holding a prestigious Q2 ranking in Parasitology and a Q3 ranking in Immunology for 2023, indicating its significant influence and relevance. Its comprehensive scope attracts a diverse readership, contributing to the discourse surrounding novel therapeutic approaches and emerging challenges in parasitic diseases. With a consistent convergence of research until 2024, PARASITE IMMUNOLOGY is an essential resource for researchers, professionals, and students seeking to deepen their knowledge and foster collaboration in these dynamic fields. Although it is not an open-access journal, the insights shared within its pages are invaluable for shaping future research trajectories.

PARASITOLOGY, published by Cambridge University Press, is a prestigious journal that has been at the forefront of research in the field of parasitology since its inception in 1908. This esteemed publication carries the ISSN 0031-1820 and E-ISSN 1469-8161, and its rigorous peer-reviewed articles provide insights into both fundamental and applied aspects of parasitic biology, infectious diseases, and host-parasite interactions. With a commendable impact factor, PARASITOLOGY ranks in the top quartile (Q1) for Animal Science and Zoology and holds Q2 rankings in both Infectious Diseases and Parasitology categories, indicating its significant influence and contribution to these disciplines. The journal's diverse scope allows for a broad range of research articles, reviews, and case studies, making it an essential resource for researchers, professionals, and students seeking to stay updated on the latest developments in the field. Based in the United Kingdom, PARASITOLOGY offers valuable access to critical research in an era where understanding parasitic diseases is more vital than ever, and continues to shape the future of this important scientific field.

AVIAN PATHOLOGY is a leading academic journal published by Taylor & Francis Ltd, focusing on the field of avian health, diseases, and diagnostics. With an ISSN of 0307-9457 and an E-ISSN of 1465-3338, this esteemed journal has been serving the scientific community since its inception in 1972, with content converging until 2024. Notably recognized in the 2023 Journal Rank, it holds a Q1 category in Animal Science and Zoology, making it an essential source for researchers and practitioners alike. The journal emphasizes critical insights into avian pathology, fostering significant advancements in veterinary science and poultry health management. Although it is not open access, subscriptions provide access to high-impact reviews and original research that underpin vital practices in the industry. With its prestigious publishing lineage and impactful scope, AVIAN PATHOLOGY continues to be a cornerstone for those dedicated to understanding and improving the health of avian species worldwide.

ACTA TROPICA is a prestigious academic journal published by Elsevier, dedicated to advancing knowledge in the fields of Infectious Diseases, Insect Science, Parasitology, and Veterinary sciences. With an ISSN of 0001-706X and an E-ISSN of 1873-6254, it has established itself as a vital resource since its inception in 1945. The journal is recognized for its significant impact within the scientific community, boasting a Q2 ranking in Infectious Diseases and Parasitology, and a Q1 ranking in both Insect Science and Veterinary (miscellaneous) categories as of 2023. Specifically, it ranks #19 in Scopus for Parasitology and #129 for Infectious Diseases, underscoring its high visibility and relevance in these vital research arenas. ACTA TROPICA is a non-open access journal, ensuring high-quality peer-reviewed content that complements ongoing research and professional practices among scientists, researchers, and students. Explore groundbreaking studies and contribute to the ongoing dialogue within your field by selecting ACTA TROPICA as your next publication destination.

Parasite Epidemiology and Control is a premier open-access journal published by Elsevier, dedicated to advancing the understanding of parasites and their impact on public health. Since its inception in 2016, the journal has established itself as a prominent publication in the fields of epidemiology, infectious diseases, and parasitology, achieving a commendable classification of Q2 in these categories as per 2023 metrics. With its ISSN 2405-6731, the journal serves as a vital resource for researchers, practitioners, and students, offering rigorous, peer-reviewed articles that illuminate parasite-related epidemiological trends and control strategies. Based in the United Kingdom, Parasite Epidemiology and Control actively promotes open access, ensuring that crucial research findings are readily accessible to a global audience, thus enhancing collaborative efforts in tackling parasitic diseases. The journal's impact is reflected in its Scopus rankings—ranking 17th in Parasitology among 79 journals, 47th in Epidemiology among 148, and 121st in Infectious Diseases among 344—underlining its significance in the scientific community. Join us in exploring this critical field and contributing to the fight against parasitic diseases through innovative research and shared knowledge.

JOURNAL OF PARASITOLOGY is a leading scholarly publication dedicated to the field of parasitology, published by ALLEN PRESS INC. With an impactful history spanning from 1945 to 2024, this journal serves as a vital resource for researchers, professionals, and students interested in the complex interactions between parasites and their hosts. Operating from its base in the United States, this journal holds a Scopus quartile ranking of Q3 in Ecology, Evolution, Behavior and Systematics, Medicine (Miscellaneous), and Parasitology, providing a solid reflection of its impact within these categories. While currently not offering Open Access, the JOURNAL OF PARASITOLOGY continues to encourage the dissemination of pivotal research findings that contribute to our understanding of parasitic diseases and ecological systems, positioning it as an indispensable tool for knowledge advancement in the life sciences.

Parasites & Vectors is a leading open access journal dedicated to the dissemination of high-quality research on the vectors of infectious diseases and their parasitic agents. Published by BMC in the United Kingdom, this journal has been at the forefront of its field since its establishment in 2008, contributing to our understanding of vector-borne pathogens through its rigorous peer-reviewed articles. With a notable impact factor and categorized in the top quartile (Q1) in both Infectious Diseases and Parasitology, it is an essential resource for researchers, professionals, and students worldwide. The journal ranks impressively within various categories, holding a position of 7th out of 194 in Veterinary General Veterinary and 12th out of 79 in Immunology and Microbiology Parasitology, indicating its significant contribution to the sciences. Accessible to all, Parasites & Vectors supports the global pursuit of knowledge in epidemiology and disease control, making it an indispensable platform for sharing innovative findings and fostering collaboration within the scientific community.

Therapeutic Advances in Infectious Disease is a distinguished journal published by SAGE Publications Ltd, dedicated to advancing knowledge in the vital field of infectious diseases and pharmacology. With an impactful Open Access model since 2019, the journal facilitates unrestricted access to a wealth of high-quality research, enabling researchers, clinicians, and educators to stay at the forefront of infectious disease management and treatment. As a recognition of its contribution to the scientific community, the journal holds a prestigious Q1 quartile ranking in both Infectious Diseases and Medical Pharmacology as of 2023, underscoring its influence and relevance in these domains. The journal is positioned favorably within the Scopus rankings, with an impressive standing in the diverse categories of Medicine, emphasizing its commitment to disseminating innovative research. Through a rigorous peer-review process and a broad scope that covers therapeutic advancements, Therapeutic Advances in Infectious Disease serves as an essential resource for anyone involved in combating infectious diseases, offering insights that drive clinical applications and enhance patient care.